Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
NLGN3 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 777 | 770 |
|
Autism Spectrum Disorders (ASD) Panel PreventionGenetics, part of Exact Sciences United States | 224 | 170 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Quantitative Genomic Medicine Laboratories, SL Spain | 328 | 300 |
|
X-Linked Intellectual Disability Panel PreventionGenetics, part of Exact Sciences United States | 191 | 141 |
|
X-chromosome High Resolution microarray analysis Pittsburgh Cytogenetics Laboratory University of Pittsburgh Medical Center United States | 240 | 171 |
|
Asperger syndrome, X-linked 1 (sequence analysis of NLGN3 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
X-linked intellectual disability panel. 99-gene NGS panel. Genologica Medica Spain | 143 | 99 |
|
Autism Spectrum Disorders Panel. NGS panel of 26 genes. Genologica Medica Spain | 39 | 26 |
|
Intellectual Disability X-linked Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 136 | 90 |
|
Intellectual Disability & Autism Spectrum Disorders Panel CNH Molecular Diagnostics Laboratory Childrens National Hospital United States | 210 | 139 |
|
Asperger syndrome (susceptibility to): Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 2 | 2 |
|
CeGaT GmbH Germany | 2 | 1 |
|
Asperger syndrome susceptibility, X-linked Bioarray Spain | 1 | 1 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5128 | 4672 |
|
XLID (X-Linked Intellectual Disability) NGS Panel Fulgent Genetics United States | 162 | 117 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.